In this study, we investigated whether pioglitazone could upregulate LRP1 expression, accompanied by reduction of Aβ plaque deposition in a mouse model of sporadic AD, senescence-accelerated mouse prone-8 (SAMP8). Here, LRP1 is linked to Alzheimer disease.